Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-06 Sale | 2024-02-08 9:08 pm | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 3,725 | $12.59 | $46,900 | 132,397 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-10 Option Award | 2024-10-15 4:15 pm | N/A 2034-10-09 | Upstream Bio Inc. | UPB | Beckman Daniella Director | 34,681 | $0 | 34,681 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 5:38 pm | N/A 2034-06-12 | Blueprint Medicines Corp | BPMC | Beckman Daniella Director | 6,812 | $0 | 15,412 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 4:10 pm | N/A 2034-05-22 | Vor Biopharma Inc. | VOR | Beckman Daniella Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:27 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 275,888 | $0 | 275,888 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 7:00 pm | N/A 2033-06-21 | Blueprint Medicines Corp | BPMC | Beckman Daniella Director | 7,900 | $0 | 13,900 (Direct) | View |
| 2023-05-26 Option Award | 2023-06-02 4:33 pm | N/A 2033-05-25 | Vor Biopharma Inc. | VOR | Beckman Daniella Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:06 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 229,893 | $0 | 293,760 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-30 9:57 pm | N/A 2032-06-21 | Blueprint Medicines Corp | BPMC | Beckman Daniella Director | 7,900 | $0 | 11,300 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:03 pm | N/A 2032-06-13 | Vor Biopharma Inc. | VOR | Beckman Daniella Director | 16,911 | $0 | 16,911 (Direct) | View |
| 2021-12-08 Option Award(A) | 2022-03-31 4:05 pm | N/A 2031-12-08 | Blueprint Medicines Corp | BPMC | Beckman Daniella Director | 10,400 | $0 | 10,400 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:30 pm | N/A 2032-02-01 | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-08-12 Option Award | 2021-08-16 7:00 pm | N/A 2031-08-12 | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 380,485 | $0 | 380,485 (Direct) | View |
Ownership | 2021-08-12 8:44 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 0 | $0 | 440,785 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-16 5:18 pm | N/A 2031-06-15 | Translate Bio Inc. | TBIO | Beckman Daniella Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:11 pm | N/A 2031-02-04 | Vor Biopharma Inc. | VOR | Beckman Daniella Director | 16,900 | $0 | 16,900 (Direct) | View |
Ownership | 2021-02-04 9:44 pm | N/A 2030-08-24 | Vor Biopharma Inc. | VOR | Beckman Daniella Director | 0 | $0 | 41,196 (Direct) | View |
| 2020-10-16 Other | 2020-10-20 8:48 pm | N/A N/A | 5:01 Acquisition Corp. | FVAM | Beckman Daniella Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-17 5:51 pm | N/A 2030-06-15 | Translate Bio Inc. | TBIO | Beckman Daniella Director | 18,900 | $0 | 18,900 (Direct) | View |